Elevair is a trademark of PneumRx, a BTG International group. The FDA has rejected PneumRx’s premarket Approval (PMA) application for the endobronchial coil system to treat of people
The post FDA rejects BTG’s emphysema treatment device Elevair appeared first on Compelo Medical Devices.
Original Article: FDA rejects BTG’s emphysema treatment device Elevair